In children with end-stage kidney disease (ESKD), a decrease in mean serum intact parathyroid hormone (iPTH) levels was observed following 6 months of cinacalcet treatment for secondary hyperparathyroidism (SHPT). This evidence concerns the gene PTH and secondary hyperparathyroidism.